Drug Trial Radar · NCT05389215
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Last checked: Nov 19, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
102
Planned (sponsor's estimate)
Start
Jul 29, 2022
Primary completion
Oct 13, 2026
Study completion Jan 30, 2027
Sponsor
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.Industry
- Sponsor type
- Industry
- First posted
- May 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blinded, placebo-controlled multicenter study to evaluate the safety and efficacy of DWN12088 in patients with Idiopathic Pulmonary Fibrosis.
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
DWN12088Drug
DWN12088 Xmg Tablet (BID)
PlaceboDrug
Placebo 0mg Tablet (BID)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of decline of FVCTime frame: From Day 1 through Week 24
- Incidents of treatment-emergent adverse eventsTime frame: From Day 1 through Week 24
Locations
30 sites in 2 countries. Site status is shown where the registry gives one.
Pulmonary Associates, PA
Mesa, Arizona
Dignity Health Norton Thoracic Institute
Phoenix, Arizona
The University of California San Francisco
San Francisco, California
Loyola University Medical Center (LUMC)
Maywood, Illinois
University of Kansas Medical Center Research Institute, Inc
Kansas City, Kansas
Tufts Medical Center
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Michigan Health System
Michigan Center, Michigan
The Lung Research Center, LLC
Chesterfield, Missouri
Duke University Medical Center
Durham, North Carolina
Pulmonix Research, LLC
Greensboro, North Carolina
Legacy Research Institute
Portland, Oregon
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
The U.S. Department of Veterans Affairs
Charleston, South Carolina
Lowcountry Lung and Critical Care
Charleston, South Carolina
Baylor Scott & White Research Institute
Dallas, Texas
The University of Texas Southwestern Medical Center
Dallas, Texas
Baylor College of Medicine
Houston, Texas
The University of Texas Health San Antonio Medical Arts & Research Center
San Antonio, Texas
Inje University Busan Paik Hospital
Busan, Busan, South Korea
The Catholic University of Korea, Bucheon St. Mary's Hospital
Bucheon-si, Gyeonggi-do, South Korea
Myongji Hospital
Goyang-si, Gyeonggi-do, South Korea
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, Gyeonggido, South Korea
Ajou University Hospital
Hwaseong-si, Gyeonggido, South Korea
Seoul National University Hospital
Seoul, Seoul, South Korea
Severance Hospital, Yonsei University Health System
Seoul, Seoul, South Korea
Asan Medical Center
Seoul, Seoul, South Korea
Samsung Medical Center
Seoul, Seoul, South Korea
Ulsan University Hospital
Ulsan, Ulsan, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.